Skip Navigation


JAC Advance Access originally published online on December 22, 2007
Journal of Antimicrobial Chemotherapy 2008 61(2):262-272; doi:10.1093/jac/dkm482
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
61/2/262    most recent
dkm482v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Shi, C.
Right arrow Articles by Eshleman, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shi, C.
Right arrow Articles by Eshleman, J. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Anti-gene padlocks eliminate Escherichia coli based on their genotype

Chanjuan Shi1,{dagger}, Antony R. Parker1,{dagger}, Li Hua1, Craig N. Morrell1,2, Soo Chin Lee3,{ddagger}, Viswanath Bandaru4, J. Stephen Dumler1, T. C. Wu1,3 and James R. Eshleman1,3,*

1 Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA 2 Department of Comparative Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA 3 Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA 4 Department of Microbiology and Molecular Genetics, The University of Vermont, 224 Stafford Hall, Burlington, VT 05405, USA

Received 23 August 2007; returned 1 October 2007; revised 16 November 2007; accepted 20 November 2007


* Corresponding author. Tel: +1-410-955-3511; Fax: +1-410-614-0671; E-mail: jeshlema{at}jhmi.edu

Objectives: Several therapeutic strategies that target nucleic acids exist; however, most approaches target messenger RNA, rather than genomic DNA. We describe a novel oligonucleotide-based strategy, called anti-gene padlocks (AGPs), which eliminate Escherichia coli based on their genotype.

Methods: The strategy employs an oligonucleotide with a double hairpin structure where both strands of the AGP are complementary to both strands of a target gene. We tested AGPs for in vitro binding and inhibition of DNA polymerization. AGPs were electroporated into bacterial cells with and without gene targets along with an ampicillin resistance plasmid, and cell survival was measured.

Results: In vitro, AGPs bound the DNA target in a sequence-dependent fashion and inhibited DNA synthesis. When transformed into bacterial cells containing 10, 20 or 30 bp lacZ or 20 bp proA DNA targets in their genomes, AGPs selectively killed or otherwise inhibited growth of these cells, while those lacking the target demonstrated little, if any, toxicity. A single transformation resulted in ~30% to 40% loss of target-bearing cells. Structure–function experiments were performed to define essential AGP requirements.

Conclusions: These results suggest that AGPs may be a useful tool to eliminate specific cell populations.

Keywords: novel therapeutics , oligonucleotide , gene targeting , antimicrobial agents , antibiotics , padlock probes


{dagger} These authors have contributed equally.

{ddagger} Present address. Department of Oncology, National University Hospital, Singapore, 5 Lower Kent Ridge Road, Singapore 119074.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.